Scientists have developed an innovative way to study serious mental health conditions by growing tiny brain-like structures in the laboratory.
Although these miniature brains are only about the size of a pea, researchers believe they could help unlock important clues about disorders such as schizophrenia and bipolar disorder, two conditions that affect millions of people worldwide.
Mental health disorders are among the most challenging medical conditions to diagnose and treat. Unlike many physical illnesses, doctors often cannot rely on a simple blood test, brain scan, or laboratory measurement to confirm a diagnosis.
Instead, they usually need to evaluate symptoms, observe behavior, and talk extensively with patients about their experiences. This process can be complicated because many symptoms overlap between different mental health conditions.
Schizophrenia and bipolar disorder are good examples of this challenge. Schizophrenia can involve hallucinations, delusions, and difficulties with thinking and perception. Bipolar disorder is characterized by major shifts in mood, energy, and activity levels.
Although these conditions are different, some symptoms can appear similar, making diagnosis difficult in certain cases. Researchers have long searched for biological signs that could help doctors distinguish between them more accurately.
A team of scientists at Johns Hopkins University has now taken an important step toward that goal. Using advanced stem cell technology, they created small brain organoids, often called mini-brains.
Stem cells are remarkable cells that can develop into many different types of cells in the body. By carefully guiding these stem cells in the laboratory, researchers can create structures that resemble certain parts of the human brain.
For this study, the researchers collected skin and blood samples from people diagnosed with schizophrenia, people diagnosed with bipolar disorder, and people without any known mental illness. They converted these samples into stem cells and then encouraged them to develop into tiny brain organoids.
These organoids are not actual human brains. They cannot think, feel emotions, form memories, or experience consciousness. However, they contain several important kinds of brain cells that allow scientists to study how brain networks develop and communicate.
The organoids were designed to resemble parts of the prefrontal cortex, a region of the brain involved in planning, decision-making, reasoning, and other higher-level mental functions.
The miniature brains also developed myelin, a fatty protective coating that surrounds nerve fibers. Myelin helps electrical signals travel rapidly and efficiently between brain cells. Healthy communication between brain cells is essential for normal brain function, and disruptions in these signals may contribute to mental health disorders.
To study how the organoids functioned, the researchers placed them onto specially designed microchips containing tiny electrodes. These electrodes recorded electrical activity from the brain cells in real time. Similar to an electroencephalogram, or EEG, the system allowed scientists to observe how the neurons communicated with one another.
When the researchers analyzed the electrical signals, they discovered clear differences between organoids grown from healthy individuals and those grown from people with schizophrenia or bipolar disorder. The neurons produced distinct patterns of activity depending on the condition from which the cells originated.
These electrical patterns appeared to act like biological fingerprints. The researchers then used machine learning, a type of artificial intelligence that can recognize patterns in large amounts of data. The computer system examined the electrical activity and attempted to identify which group each organoid belonged to.
The results were impressive. Initially, the system correctly classified the organoids with an accuracy of up to 83 percent. The researchers then applied gentle electrical stimulation to encourage more activity within the mini-brains. After this stimulation, the accuracy increased to 92 percent.
This finding suggests that schizophrenia and bipolar disorder may each have unique electrical signatures within brain networks. Scientists refer to these patterns as electrophysiological signatures, meaning characteristic patterns of electrical activity produced by brain cells.
If future studies confirm these findings, doctors may eventually have access to more objective tools for diagnosing mental health conditions.
The research may also help improve treatment. Currently, finding the right medication often involves trial and error. Patients may spend months or even years trying different drugs before discovering one that effectively manages their symptoms. Some people do not respond well to commonly prescribed medications, including treatments such as clozapine.
In the future, doctors may be able to test medications directly on a patient’s own lab-grown brain organoids before prescribing them. By observing how the mini-brains respond to different drugs, researchers could potentially predict which treatment would work best for a specific individual.
This personalized approach could reduce unnecessary side effects and shorten the time needed to find effective treatment.
The study involved samples from only 12 patients, so larger studies will be necessary before the findings can be applied in clinical practice. The research team is already collaborating with other experts to collect more samples and investigate how different medications and dosages affect the organoids.
Although there is still much work to be done, the study offers an exciting glimpse into the future of mental health research. Tiny lab-grown brain organoids may eventually provide scientists with a powerful new tool for understanding psychiatric disorders, improving diagnosis, and developing more personalized treatments.
The research was published in the journal APL Bioengineering. The scientists hope that continued advances in this field will lead to faster diagnoses, more effective treatments, and better outcomes for people living with serious mental health conditions around the world.
If you care about health, please read studies that scientists find a core feature of depression and this metal in the brain strongly linked to depression.
For more health information, please see recent studies about drug for mental health that may harm the brain, and results showing this therapy more effective than ketamine in treating severe depression.
Copyright © 2026 Knowridge Science Report. All rights reserved.
